What question did this study set out to answer?

To evaluate the clinical presentation, diagnostic modalities, and current therapeutic management strategies for myocarditis and associated cardiomyopathy.

March 11, 2018Current Opinion in Cardiology

Myocarditis and cardiomyopathy

View Full Paper

Ask AI

Bookmark

To evaluate the clinical presentation, diagnostic modalities, and current therapeutic management strategies for myocarditis and associated cardiomyopathy.
Synthesized evidence on clinical manifestations and pathophysiological mechanisms underlying myocarditis-related myocardial injury.
Evaluated the diagnostic utility of noninvasive cardiac MRI compared with the gold-standard endomyocardial biopsy.
Reviewed conventional pharmacotherapies, supportive interventions, and advanced therapies including mechanical circulatory support and cardiac transplantation.
Cardiac MRI substantially improves noninvasive diagnostic capabilities, although endomyocardial biopsy remains the definitive gold standard for confirmation.
Management strategies remain largely limited to standard supportive heart failure pharmacotherapies, with mechanical circulatory support or heart transplantation required for end-stage cases.

Design

Review

Implication

Biopsy remains essential and HF therapy standard despite MRI gains; leaves open targeted therapies and noninvasive alternatives.

Abstract

Although overall myocarditis accounts for a minority of cardiomyopathy and heart failure presentations, the clinical presentation is variable and the pathophysiology of myocardial damage is unique. Cardiac MRI has significantly improved diagnostic abilities, but endomyocardial biopsy remains the gold standard. However, current treatment strategies are still focused on routine heart failure pharmacotherapies and supportive care or cardiac transplantation/mechanical support for those with end-stage heart failure.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Buggey et al. (2018) studied this question.

synapsesocial.com/papers/69d56b4175589c71d767c9bc https://doi.org/10.1097/hco.0000000000000514

Topics

View Full Paper

Ask AI

Bookmark

Implication

Biopsy remains essential and HF therapy standard despite MRI gains; leaves open targeted therapies and noninvasive alternatives.

Myocarditis and cardiomyopathy

Key Points

Implication

Abstract

Discussion

Cite This Study

Topics

Myocarditis and cardiomyopathy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Topics

Keep reading